SERPINE1 and type 2 diabetes mellitus: Insulin resistance in patients with type 2 diabetes or obesity leads to an increase in PAI-1 and high levels throughout the day compared to normal individuals, creating an environment of reduced fibrinolysis that promotes the development of cardiovascular complications.